Prognostic value of the timing of immune checkpoint inhibitors infusion in patients with advanced hepatocellular carcinoma

被引：0
|
作者：
Pascale, Alina [1 ]
Allard, Marc Antoine [2 ]
Benamar, Amal [1 ]
Levy, Francis [2 ]
Adam, Rene [2 ]
Rosmorduc, Olivier [3 ]
机构：
[1] CHU Paul Brousse, AP HP, Villejuif, France
[2] Univ Paris Saclay, CHU Paul Brousse, AP HP, Villejuif, France
[3] Paris Sorbonne Univ, CHU Paul Brousse, AP HP, Villejuif, France
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-491
引用
收藏
页码：S452 / S452
页数：1
相关论文
共 50 条
  • [1] Prognostic value of the timing of immune checkpoint inhibitors infusion in patients with advanced hepatocellular carcinoma
    Pascale, Alina
    Allard, Marc Antoine
    Benamar, Amal
    Levi, Francis
    Adam, Rene
    Rosmorduc, Olivier
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 457 - 457
  • [2] Adverse events of immune checkpoint inhibitors in advanced hepatocellular carcinoma and their prognostic significance
    Wilhelmi, Markus
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (04) : 483 - 483
  • [3] Prognostic value of nutritional and inflammatory markers in patients with hepatocellular carcinoma who receive immune checkpoint inhibitors
    Liu, Chunxun
    Zhao, Haoran
    Zhang, Rujia
    Guo, Zuoming
    Wang, Peng
    Qu, Zhaowei
    ONCOLOGY LETTERS, 2023, 26 (04)
  • [4] Advances in Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma
    Chen, Yue
    Hu, Haoyue
    Yuan, Xianglei
    Fan, Xue
    Zhang, Chengda
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [5] Clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with locally advanced NSCLC
    Hirata, T.
    Uehara, Y.
    Hakozaki, T.
    Terashima, Y.
    Watanabe, K.
    Yomota, M.
    Hosomi, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S1659 - S1659
  • [6] Prognostic biomarkers associated with immune checkpoint inhibitors in hepatocellular carcinoma
    Chen, Xiu
    Kou, Liqiu
    Xie, Xiaolu
    Su, Song
    Li, Jun
    Li, Yaling
    IMMUNOLOGY, 2024, 172 (01) : 21 - 45
  • [7] Progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma
    Liu, Tong
    Meng, Guorui
    Ma, Shihui
    You, Junqi
    Yu, Liang
    He, Risheng
    Zhao, Xudong
    Cui, Yunfu
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [8] Immune checkpoint inhibitors for hepatocellular carcinoma
    El Dika, Imane
    Khalil, Danny N.
    Abou-Alfa, Ghassan K.
    CANCER, 2019, 125 (19) : 3312 - 3319
  • [9] Immune checkpoint inhibitors for hepatocellular carcinoma
    Jensen, Christopher E.
    Loaiza-Bonilla, Arturo
    Bonilla-Reyes, Paula A.
    HEPATIC ONCOLOGY, 2016, 3 (03) : 201 - 211
  • [10] Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?
    Lee, J.
    Ng, K.
    Wong, L.
    Ang, A.
    Tan, S. H.
    Tai, D.
    Choo, S. P.
    ANNALS OF ONCOLOGY, 2019, 30 : 23 - 23
12345